FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a ...
Tag: Lymphopenia
What are the associations of metabolome, microbiome, and immune perturbations with severe COVID-19?
In a recent study posted to the bioRxiv* preprint server, researchers observed that coronavirus disease 2019 (COVID-19) progression and inflammatory responses ...
Exploring the biomarker profiles in severe COVID-19
In a recent study published in the Frontiers in Medicine journal, researchers estimated the D-dimer levels and characterized lymphocyte subsets ...
The severity of COVID-19 compared to seasonal influenza
In a recent study under review at the Archives of Virology journal and currently posted to the Research Square* preprint server, ...
